1. Home
  2. PAAS vs VTRS Comparison

PAAS vs VTRS Comparison

Compare PAAS & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAAS
  • VTRS
  • Stock Information
  • Founded
  • PAAS 1994
  • VTRS 1961
  • Country
  • PAAS Canada
  • VTRS United States
  • Employees
  • PAAS N/A
  • VTRS N/A
  • Industry
  • PAAS
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • PAAS
  • VTRS Health Care
  • Exchange
  • PAAS Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • PAAS 11.8B
  • VTRS 11.8B
  • IPO Year
  • PAAS 1995
  • VTRS N/A
  • Fundamental
  • Price
  • PAAS $34.60
  • VTRS $10.50
  • Analyst Decision
  • PAAS Buy
  • VTRS Hold
  • Analyst Count
  • PAAS 4
  • VTRS 5
  • Target Price
  • PAAS $33.25
  • VTRS $10.40
  • AVG Volume (30 Days)
  • PAAS 4.6M
  • VTRS 9.1M
  • Earning Date
  • PAAS 11-04-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • PAAS 1.21%
  • VTRS 4.57%
  • EPS Growth
  • PAAS N/A
  • VTRS N/A
  • EPS
  • PAAS 1.44
  • VTRS N/A
  • Revenue
  • PAAS $3,116,300,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • PAAS $15.86
  • VTRS N/A
  • Revenue Next Year
  • PAAS $5.79
  • VTRS $1.66
  • P/E Ratio
  • PAAS $24.02
  • VTRS N/A
  • Revenue Growth
  • PAAS 21.09
  • VTRS N/A
  • 52 Week Low
  • PAAS $18.50
  • VTRS $6.85
  • 52 Week High
  • PAAS $35.00
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • PAAS 69.08
  • VTRS 61.05
  • Support Level
  • PAAS $33.33
  • VTRS $10.29
  • Resistance Level
  • PAAS $35.00
  • VTRS $10.61
  • Average True Range (ATR)
  • PAAS 0.90
  • VTRS 0.19
  • MACD
  • PAAS 0.12
  • VTRS -0.05
  • Stochastic Oscillator
  • PAAS 90.93
  • VTRS 45.76

About PAAS Pan American Silver Corp.

Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: